Rchr
J-GLOBAL ID:202201020023467153   Update date: Oct. 15, 2024

Nagae Genta

Nagae Genta | Nagae Genta
Affiliation and department:
Job title: Project Associate Professor
Homepage URL  (2): https://www.rcast.u-tokyo.ac.jp/ja/research/people/staff-nagae_genta.htmlhttps://www.rcast.u-tokyo.ac.jp/en/research/people/staff-nagae_genta.html
Research field  (4): Genomics ,  Gastroenterology ,  Systems genomics ,  Tumor biology
Research theme for competitive and other funds  (21):
  • 2024 - 2029 A Study on Elucidating Obesity and Lifestyle Diseases through the Epigenome-RNA Modification Axis
  • 2023 - 2026 Exploring Abnormal RNA Modifications in Glioma using direct RNA Nanopore Sequencing
  • 2023 - 2026 脳腫瘍の免疫血管微小環境と放射線画像radiomics解析の融合を基にした新規治療開発
  • 2024 - 2026 Elucidation of therapeutic resistance caused by complex molecular aberrations and tumor microenvironment
  • 2021 - 2025 Elucidation of mRNA dysregulation in hepatocellular carcinoma using a novel mRNA methylome method
Show all
Papers (70):
  • Takeshi Marumo, Naoto Yoshida, Noriko Inoue, Masayuki Yamanouchi, Yoshifumi Ubara, Shinji Urakami, Takeshi Fujii, Yutaka Takazawa, Kenichi Ohashi, Wakako Kawarazaki, et al. Aberrant proximal tubule DNA methylation underlies phenotypic changes related to kidney dysfunction in patients with diabetes. American journal of physiology. Renal physiology. 2024. 327. 3. F397-F411
  • Akira Nishijima, Katsutoshi Oda, Kosei Hasegawa, Takahiro Koso, Kayo Asada, Yuji Ikeda, Ayumi Taguchi, Daichi Maeda, Genta Nagae, Shingo Tsuji, et al. Integrated genomic/epigenomic analysis stratifies subtypes of clear cell ovarian carcinoma, highlighting their cellular origin. Scientific reports. 2024. 14. 1. 18797-18797
  • Sina Neyazi, Erika Yamazawa, Karoline Hack, Shota Tanaka, Genta Nagae, Catena Kresbach, Takayoshi Umeda, Alicia Eckhardt, Kenji Tatsuno, Lara Pohl, et al. Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation. Acta Neuropathologica. 2024. 147. 1
  • Amélie Roehrig, Theo Hirsch, Aurore Pire, Guillaume Morcrette, Barkha Gupta, Charles Marcaillou, Sandrine Imbeaud, Christophe Chardot, Emmanuel Gonzales, Emmanuel Jacquemin, et al. Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastoma. Nature Communications. 2024. 15. 1. 3031-3031
  • Aurore Pire, Theo Z. Hirsch, Guillaume Morcrette, Sandrine Imbeaud, Barkha Gupta, Jill Pilet, Marianna Cornet, Monique Fabre, Catherine Guettier, Sophie Branchereau, et al. Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survival. European Journal of Cancer. 2024
more...
MISC (21):
  • 柴田龍弘. がんゲノムペディア -77のキーワードで理解するゲノム医療とゲノム研究. 2024. 104-107
  • 永江玄太. 総論:疾患の病態解明に向けた統合オミックス解析. 遺伝子医学 統合オミックス解析. 2023. 13. 3
  • 永江 玄太. 小児肝芽腫発症に関与する分化制御因子. 生化学. 2022. 94. 3. 438-442
  • 永江 玄太. 【がんゲノム医療時代の分子腫瘍学】(第1部)がんの分子病理学(序論) 解析法 ヒトゲノム研究におけるマイクロアレイ解析(CGH・SNP・メチル化など). 病理と臨床. 2022. 40. 臨増. 057-063
  • 永江 玄太. 泌尿器科領域におけるシングルセル解析の可能性. 泌尿器科. 2022. 15. 4. 465-471
more...
Patents (3):
Education (2):
  • - 2008 The University of Tokyo Graduate School of Medicine
  • - 2000 The University of Tokyo Faculty of Medicine School of Medicine
Professional career (2):
  • M.D. (The University of Tokyo)
  • Ph.D. (The University of Tokyo)
Work history (10):
  • 2021/04 - 現在 The University of Tokyo Research Center for Advanced Science and Technology Project Associate Professor
  • 2017/07 - 2021/03 The University of Tokyo Research Center for Advanced Science and Technology Lecturer
  • 2018/04 - 2019/03 University of Cambridge Clare Hall College Visiting Fellow
  • 2018/04 - 2019/03 Wellcome Sanger Institute Visiting Scientist
  • 2015/10 - 2017/06 The University of Tokyo Research Center for Advanced Science and Technology Project Lecturer
Show all
Committee career (1):
  • 2022/01 - 現在 日本癌学会 評議員
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page